Login

Jan Anders Karlsson, CEO, Verona Pharma 00:00:00

Share On Facebook Share On Twitter

Verona Pharma can make real difference to COPD market believes CEO Karlsson

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Oisin Hanrahan on Leadership and Company Culture at Angi | Oisin Hanrahan, CEO, Angi Inc.
00:10:00
Green Technology Metals' Lithium Project Progress and Future Plans
00:10:00
Jennifer Chow discusses promising results of cltx C therapy, signaling future trials and regulatory milestones in cancer treatment | Jennifer Chow, CEO,Chimeric Therapeutics Ltd.
00:10:00
Copper Bank Corp.: Strategic Focus on Non-Dilutive, High-Yield Copper Investments
00:10:00
12 Questions with Veganz Founder and CEO Jan Bredack | Jan Bredack, CEO , Veganz Group AG.
00:10:00
Cyient DLM Launches IPO, Aiming to Raise Rs 592 Crore with Shares at Rs 250–265 Each | KRISHNA BODANAPU , Chairman, Cyient DLM Ltd.
00:10:00
The Uranium market and its potential for growth and investment opportunities|Brandon Munro,CEO,Bannerman Energy
00:10:00
Arie Kotler Addresses February Consumer Spending Decline and ARKO's EV Infrastructure Plans | Arie Kotler, CEO, ARKO Corp.
00:10:00
Guy Hands on Brexit's Impact: U.K. Exports, Investment Strategy, and ESG in M&A | Guy Hands, Chairman, Terra Firma Capital Partners.
00:10:00
Reducing Audit Costs: Insights from Erez Bahar | EREZ BAHAR, Managing Partner at Davidson & Company LLP
00:10:00
We are Committed to making the world a better place|Hans Vestberg,Chairman,Verizon Asset Management Corp.
00:10:00
Profiles: Scott Belsky of Benchmark and Jeremy Levine of Bessemer Venture Partners

© 2017 - Neuhu+